Diclofenac Sodium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

73 Suppliers, 21 USDMF, 16 CEP/COS, 13 JDMF, 7 EU WC, 20 KDMF, 27 NDC API, 43 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

479 Dossiers, 99 FDA Orange Book, 121 Europe, 38 Canada, 62 South Africa, 159 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 2%, TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG, TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG, SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1%, SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 48 BASF, 38 Kerry, 24 Roquette, 18 Corel Pharma Chem, 16 Microlex e.U, 15 Seppic, 15 Actylis, 14 Ideal Cures Pvt Ltd, 12 Sigachi Industries, 12 Gangwal Chemicals, 12 Boai NKY Pharmaceuticals Ltd, 11 SPI Pharma, 11 Nanjing Well Pharmaceutical, 10 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 DKSH, 4 Pharmatrans-Sanaq, 4 Vasa Pharmachem, 4 Prachin Chemical, 4 Alcedo Pharmachem, 4 Ingredion Pharma Solutions, 4 Ulanqab Kema New Material, 3 Finar, 3 Kima Chemical, 3 Doshion Polyscience, 3 Aeon Procare, 2 Nanjing Bold Chemical, 2 Lubrizol Life Science Health, 2 Nomisma Healthcare, 2 Seqens, 2 The Dow Chemical Company, 2 Valens Pharmachem, 2 Jai Radhe Sales, 2 Evonik, 2 Shandong Focus Biotechnology Co., Ltd, 2 Pfanstiehl, 1 Huzhou Sunflower Pharmaceutical, 1 Vertellus, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 ACG Worldwide, 1 BioSpectra, 1 Qualicaps, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 72 Coating Systems & Additives, 49 Controlled & Modified Release, 47 Solubilizers, 45 Direct Compression, 41 Disintegrants & Superdisintegrants, 36 Topical, 36 Thickeners and Stabilizers, 34 Granulation, 27 Parenteral, 24 Lubricants & Glidants, 23 Film Formers & Plasticizers, 20 Taste Masking, 19 Co-Processed Excipients, 17 Emulsifying Agents, 10 Chewable & Orodispersible Aids, 9 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers

GLOBAL SALES INFORMATION

117 Finished Drug Prices

117 Finished Drug Prices

MARKET PLACE

60 APIs, 23 DOSSIERS // FDF

PATENTS

26 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 BioAnalytical Methods, 2 EDQM, 1 USP, 1 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 63 News

Annual Sales of Diclofenac Sodium reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Diclofenac Sodium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

73 Suppliers

21 USDMF

16 CEP/COS

13 JDMF

7 EU WC

20 KDMF

27 NDC API

43 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

479 Dossiers

99 FDA Orange Book

121 Europe

38 Canada

62 South Africa

159 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 2%

TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG

TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG

SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1%

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

48 BASF

38 Kerry

24 Roquette

18 Corel Pharma Chem

16 Microlex e.U

15 Seppic

15 Actylis

14 Ideal Cures Pvt Ltd

12 Sigachi Industries

12 Gangwal Chemicals

12 Boai NKY Pharmaceuticals Ltd

11 SPI Pharma

11 Nanjing Well Pharmaceutical

10 Gangwal Healthcare

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 DFE Pharma

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 DKSH

4 Pharmatrans-Sanaq

4 Vasa Pharmachem

4 Prachin Chemical

4 Alcedo Pharmachem

4 Ingredion Pharma Solutions

4 Ulanqab Kema New Material

3 Finar

3 Kima Chemical

3 Doshion Polyscience

3 Aeon Procare

2 Nanjing Bold Chemical

2 Lubrizol Life Science Health

2 Nomisma Healthcare

2 Seqens

2 The Dow Chemical Company

2 Valens Pharmachem

2 Jai Radhe Sales

2 Evonik

2 Shandong Focus Biotechnology Co., Ltd

2 Pfanstiehl

1 Huzhou Sunflower Pharmaceutical

1 Vertellus

TABLET, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 1.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;TOPICAL - 3% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons